SLC30A9 and cervical cancer: Our findings indicate that silencing or knockout the zinc transporter SLC30A9 in pCCa-1 cervical cancer cells leads to a significant increase in mitochondrial zinc (Zn 2+) levels, a result consistent with previous research [31].